Free Trial

AEON Biopharma (AEON) Insider Trading & Ownership

AEON Biopharma logo
$0.65 +0.00 (+0.08%)
(As of 12/20/2024 05:15 PM ET)

AEON Biopharma (NASDAQ:AEON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
23.50%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$73.80 M
Get AEON Insider Trade Alerts

Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AEON Insider Buying and Selling by Quarter

AEON Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2023Crown Holdings Grou StrathspeyMajor ShareholderSell7,380,394$10.00$73,803,940.00  
(Data available from 1/1/2013 forward)

AEON Insider Trading Activity - Frequently Asked Questions

The list of insiders at AEON Biopharma includes Crown Holdings Grou Strathspey. Learn more on insiders at AEON.

23.50% of AEON Biopharma stock is owned by insiders. Learn more on AEON's insider holdings.

The following insider sold AEON shares in the last 24 months: Crown Holdings Grou Strathspey ($73,803,940.00).

Insiders have sold a total of 7,380,394 AEON Biopharma shares in the last 24 months for a total of $73,803,940.00 sold.

AEON Biopharma Key Executives

  • Mr. Marc Forth (Age 53)
    Principal Financial Officer, President, CEO & Director
    Compensation: $948.75k
  • Mr. Alex Wilson (Age 37)
    Executive VP, Chief Legal Officer & Corporate Secretary
    Compensation: $517.4k
  • Dr. Chad K. Oh M.D. (Age 65)
    Chief Medical Officer
    Compensation: $561k
  • Ms. Jennifer Sy (Age 39)
    Principal Accounting Officer


This page (NASDAQ:AEON) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners